Cautious Outlook on Zura Bio: Neutral Rating Due to Clinical Challenges and Financial Uncertainty
Analyst Mitchell Kapoor from H.C. Wainwright reiterated a Hold rating on Zura Bio (ZURA – Research Report) and keeping the price target ...